4. THE EFFICACY OF SECOND-LINE TREATMENT WITH DOCETAXEL FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER STAGE IIIB-IV AT E HOSPITAL. YHCĐ 2022, 64 (1). https://doi.org/10.52163/yhc.v64i1.567.